TWD 37.6
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 90 Thousand TWD | -82.89% |
2022 | 526 Thousand TWD | 46.11% |
2021 | 360 Thousand TWD | -99.6% |
2020 | 90.76 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -1.56 Million TWD | 0.0% |
2024 Q1 | - TWD | -100.0% |
2023 Q2 | - TWD | 0.0% |
2023 Q4 | 45 Thousand TWD | 0.0% |
2023 Q1 | - TWD | -100.0% |
2023 FY | 90 Thousand TWD | -82.89% |
2023 Q3 | 45 Thousand TWD | 0.0% |
2022 Q3 | 263 Thousand TWD | 0.0% |
2022 FY | 526 Thousand TWD | 46.11% |
2022 Q4 | 263 Thousand TWD | 0.0% |
2021 FY | 360 Thousand TWD | -99.6% |
2020 FY | 90.76 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | 72.644% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 99.978% |
Level Biotechnology Inc. | 219.54 Million TWD | 99.959% |
Sagittarius Life Science Corp | 71.47 Million TWD | 99.874% |
NeoCore Technology Co., Ltd. | -9.08 Million TWD | 100.991% |
TaiMed Biologics Inc. | 225.23 Million TWD | 99.96% |
GlycoNex Incorporation | 995 Thousand TWD | 90.955% |
VBI | 16.42 Million TWD | 99.452% |
GeneReach Biotechnology Corp. | 27.58 Million TWD | 99.674% |
Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 99.955% |
SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | 82.726% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 99.925% |
Visgeneer Inc. | 67.48 Million TWD | 99.867% |
Mycenax Biotech Inc. | -375.19 Million TWD | 100.024% |
Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 99.994% |
G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 99.938% |
Neith Corporation | 18.01 Million TWD | 99.501% |
Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 99.961% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 99.604% |
Enimmune corporation | -23.37 Million TWD | 100.385% |
TaiRx, Inc. | 2.43 Million TWD | 96.31% |
CHO Pharma, Inc. | -28.27 Million TWD | 100.318% |
EirGenix Inc. | 236.74 Million TWD | 99.962% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 99.914% |
Sunny Pharmtech Inc. | 285.52 Million TWD | 99.968% |
Lin BioScience, Inc. | -17.92 Million TWD | 100.502% |
BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 99.9% |
Feng Chi Biotech Corp. | 80.72 Million TWD | 99.889% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | 91.69% |
Lukas Biomedical Inc. | 133.89 Million TWD | 99.933% |
RBC Bioscience Corporation | 72.89 Million TWD | 99.877% |
BiOptic Inc. | 152.74 Million TWD | 99.941% |
Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | 98.65% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | 96.558% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.986% |
Advagene Biopharma Co., Ltd. | -12 Million TWD | 100.75% |
NaviFUS Corp. | 11.82 Million TWD | 99.239% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 99.907% |
Sinew Pharma Inc. | -28.98 Million TWD | 100.311% |
Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | 71.246% |
Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 99.977% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 99.783% |
AP Biosciences Inc | 32.25 Million TWD | 99.721% |
Medigen Biotechnology Corp. | 617.32 Million TWD | 99.985% |
3D Global Biotech Inc. | 5.27 Million TWD | 98.294% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 99.971% |
Intech Biopharm Corporation | -163.99 Million TWD | 100.055% |
Oneness Biotech Co., Ltd. | 32.56 Million TWD | 99.724% |
Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 102.234% |
TWi Biotechnology, Inc. | -9.73 Million TWD | 100.924% |
Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 99.981% |
TCI GENE Inc. | 174.61 Million TWD | 99.948% |
MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 100.542% |
Senhwa Biosciences, Inc. | -10.17 Million TWD | 100.885% |
Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 99.882% |
NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 99.883% |
PharmaEngine, Inc. | 718.97 Million TWD | 99.987% |
Savior Lifetec Corporation | 220.94 Million TWD | 99.959% |
TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 99.919% |
OBI Pharma, Inc. | -73.49 Million TWD | 100.122% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 99.935% |
Acepodia, Inc. | 16.59 Million TWD | 99.458% |
Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | 99.672% |